+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Finland

  • PDF Icon

    Report

  • 22 Pages
  • September 2024
  • Region: Finland
  • Euromonitor International
  • ID: 224156
In 2024, analgesics in Finland is facing maturity and seeing current value sales dip. Analgesics has experienced a fluctuating performance in the last few years, as demand has been significantly impacted by the dramatic changes to consumer lifestyles resulting from the COVID-19 crisis. With the outbreak of COVID-19 in 2020, many consumers panic bought these products and stocked up. Then demand fell in 2021, as consumers first finished the analgesics they had stocked up on.

The Analgesics in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Value sales decline for analgesics
  • Topical analgesics sees growth rise, while Orion Oyi maintains overall leadership
  • Paediatric analgesics continues to expand from a small base
PROSPECTS AND OPPORTUNITIES
  • Analgesics faces disappointing forecast period
  • Innovation to drive unit price growth
  • Smaller segments set to perform well
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2019-2024
  • Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
  • Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
  • Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN FINLAND
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources